Drug Shortage Report for LEUKERAN
| Report ID | 153003 |
| Drug Identification Number | 00004626 |
| Brand name | LEUKERAN |
| Common or Proper name | chlorambucil |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | CHLORAMBUCIL |
| Strength(s) | 2MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 25 Tablets |
| ATC code | L01AA |
| ATC description | ALKYLATINGAGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-06-15 |
| Actual start date | |
| Estimated end date | 2022-08-01 |
| Actual end date | 2022-01-31 |
| Shortage status | Avoided shortage |
| Updated date | 2022-01-31 |
| Company comments | GR82646CA1 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2030 BRISTOL CIRCLE, SUITE 201 OAKVILLE, ONTARIO CANADA L6H 0H2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-01-31 | French | Compare |
| v3 | 2022-01-31 | English | Compare |
| v2 | 2022-01-18 | French | Compare |
| v1 | 2022-01-18 | English | Compare |
Showing 1 to 4 of 4